Opioid use disorders are highly prevalent among criminal justice populations. According to data from the U.S. Department of Justice, approximately half of state and federal prisoners meet criteria for substance use disorder. Even so, there has been reticence in criminal justice settings to using medications (methadone, buprenorphine, naltrexone) to treat opioid use disorders. In national surveys, utilization of these medications is very low in criminal justice settings, including drug courts, jails, and prisons. Thus, opioid use disorder goes largely untreated during periods of incarceration, and opioid use often resumes after release.
Treatment of Opioid Use Disorder in the Criminal Justice System (2017)
Notice about external resources
These links are being provided as a convenience and for informational purposes only; they do not constitute an endorsement or an approval by the National Institute of Corrections (NIC) of any of the products, services or opinions of the corporation or organization or individual. NIC bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links. Contact the external site for answers to questions regarding its content.